We are live on ! Find out more
ACA

Avoro Capital Advisors Portfolio holdings

AUM $10.2B
1-Year Est. Return 149.19%
This Fund
S&P 500
This Quarter Est. Return
+20.46%
1 Year Est. Return
+149.19%
3 Year Est. Return
+425.03%
5 Year Est. Return
+775.33%
10 Year Est. Return
+45,729.2%
AUM
$261M
AUM Growth
+$113M
Cap. Flow
+$81.2M
Cap. Flow %
31.18%
Top 10 Hldgs %
68.46%
Holding
45
New
14
Increased
8
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$24.2M
2
CELG
Celgene Corp
CELG
+$17.8M
3
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$15.1M
4
FOLD
Amicus Therapeutics
FOLD
+$12.2M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$7.53M

Top Sells

Rank Stock Value
1
MGNX icon
MacroGenics
MGNX
+$5.7M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$5.5M
3
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$4.62M
4
ARWR icon
Arrowhead Research
ARWR
+$3.88M
5
DVAX
Dynavax Technologies
DVAX
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 83.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXDX
26
DELISTED
Ignyta, Inc.
RXDX
$2M 0.77%
200,772
-320,461
-61% -$2.4M
INNL
27
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$1.69M 0.65%
225,000
– –
SCPX
28
DELISTED
Scorpius Holdings, Inc.
SCPX
$1.65M 0.63%
+1
New +$1.65M
BIOL
29
DELISTED
Biolase, Inc.
BIOL
$1.39M 0.54%
55
-8
-13% -$227K
GYRE icon
30
Gyre Therapeutics
GYRE
$681M
$1.39M 0.53%
+592
New +$1.22M
CLLS
31
Cellectis
CLLS
$277M
$1.04M 0.4%
+30,000
New +$1.09M
ALIM
32
DELISTED
Alimera Sciences
ALIM
$408K 0.16%
5,425
-39,548
-88% -$3.11M
ARWR icon
33
Arrowhead Research
ARWR
$12.1B
– –
-525,000
Closed -$3.88M
CPRX
34
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-550,670
Closed -$1.64M
DVAX
35
DELISTED
Dynavax Technologies
DVAX
– –
-199,332
Closed -$3.36M
EXAS
36
PUT
DELISTED
Exact Sciences
EXAS
– –
-9,600
Closed -$4K
HRTX icon
37
Heron Therapeutics
HRTX
$96.8M
– –
-65,900
Closed -$663K
MGNX icon
38
MacroGenics
MGNX
$243M
– –
-162,500
Closed -$5.7M
NVAX icon
39
Novavax
NVAX
$1.22B
– –
-15,000
Closed -$1.78M
VXRT
40
DELISTED
Vaxart
VXRT
– –
-23,508
Closed -$579K
FWP
41
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
– –
-7,143
Closed -$1.04M
RCPT
42
PUT
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-20,000
Closed -$82K
CELG
43
CALL
DELISTED
Celgene Corp
CELG
– –
-150,000
Closed -$3.92M
1
2

Similar funds

IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Avoro Capital Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Avoro Capital Advisors held 45 positions worth $261M, up 77% from $148M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Avoro Capital Advisors deployed $81.2M of net new capital in Q1 2015, opening 14 new positions and adding to 8 existing holdings. Its largest new stake was Iovance Biotherapeutics: 2,149,907 shares worth $26M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 81% a quarter earlier.

On the sell side, the largest reduction was RECEPTOS INC COM STK (DE), an estimated $5.5M trimmed.

  • Avoro Capital Advisors's largest Q1 2015 buy was Iovance Biotherapeutics: 2,149,907 shares worth $26M.
  • Avoro Capital Advisors added most to Sorrento Therapeutics, Inc. in Q1 2015, an estimated $15.1M increase.
  • Avoro Capital Advisors's biggest Q1 2015 reduction was RECEPTOS INC COM STK (DE), cutting an estimated $5.5M.
  • Avoro Capital Advisors fully exited MacroGenics in Q1 2015, selling an estimated $5.7M.
  • Avoro Capital Advisors's ten largest holdings make up 68% of its $261M portfolio in Q1 2015.
  • Avoro Capital Advisors opened 14 new positions and closed 12 in Q1 2015.
  • Avoro Capital Advisors's portfolio value rose 77% quarter-over-quarter to $261M.

Based on Avoro Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.